Home›Stock Screener›Sakar Healthcare

Sakar Healthcare Share Price Today | Stock Price & Sakar Healthcare Share Screener

SAKAR Pharmaceuticals
Live Share Price NSE
₹1006.80
▼ -68.20 (-6.34%)
2026-10-05 00:00:00

As of October 5, 2026, the live Sakar Healthcare share price (NSE: SAKAR) is ₹1,006.80, down 6.34% from the previous close, with shares trading between ₹985.00 and ₹1,094.00 in today's trading session, and a 52-week range of ₹353.00–₹1,188.40. Check Sakar Healthcare yearly highs lows for the annual price range and momentum. Use the Sakar Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sakar Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹75 and net income of ₹10, with EBITDA of ₹23, an operating margin of 29.0% and a profit margin of 13.3%.

Sakar Healthcare Market Cap ₹2,432.03 Cr.
SAKAR P/E Ratio (TTM) 69.16
Sakar Healthcare P/B Ratio 7.69
EPS (TTM) ₹13.70
Dividend Yield -
Debt to Equity 0.26
SAKAR 52 Week High ₹1188.40
Sakar Healthcare 52 Week Low ₹353.00
Operating Margin 29.00%
Profit Margin 13.33%
SAKAR Revenue (TTM) ₹75.00
EBITDA ₹23.00
Net Income ₹10.00
Total Assets ₹481.00
Total Equity ₹325.00

Sakar Healthcare Share Price Chart

Track the current stock price of Sakar Healthcare with an interactive chart. Analyse SAKAR share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sakar Healthcare stock quote in one place.

The quote of ₹1,006.80 sits between the 52-week low of ₹353.00 and the 52-week high of ₹1,188.40, and the latest session moved -6.34% from the previous close.

Sakar Healthcare Company Profile - Fundamental Screener

Screen Sakar Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SAKAR shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE732S01012.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE732S01012

Sakar Healthcare Balance Sheet Screener

Screen SAKAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹481, up from ₹415 in 2025.

Latest statistics put total assets at ₹481 and shareholder funds at ₹325, with a leverage ratio of 0.26.

Item 2026 2025 2024 2023 2022 2021 2020

Assets

Total Assets 481 415 389 336 268 178 115
Current Assets 141 89 72 56 50 34 22
Fixed Assets 327 309 314 267 205 69 66

Liabilities

Total Liabilities 0 0 0 0 0 0 0
Current Liabilities 47 67 67 109 94 46 20
Non-Current Liabilities 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 325 286 262 173 128 99 81
Share Capital 22 22 22 19 17 16 15
Reserves & Surplus 302 261 236 154 110 83 66

Sakar Healthcare Income Statement Screener - Profit & Revenue Analysis

Screen Sakar Healthcare income statement and profit fundamentals. Analyze SAKAR quarterly results. Sakar Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹75 and net profit was ₹10, equal to earnings per unit of ₹4.62, at an operating margin of 29%.

In that period expenses were ₹52, interest cost ₹2 and tax ₹4. The next period listed, 2026-Mar, shows revenue of ₹71 and net profit of ₹11.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec

Revenue and Expenses

Revenue 75 71 71 59 53 50 44 43 42 44 38 35 41 43 35
Expenses 52 45 52 46 40 35 32 31 31 32 28 25 30 33 25

Operating Costs and Margins

EBITDA 23 26 19 13 13 16 12 12 11 12 9 10 11 10 11
Operating Profit % 29.00% 37.00% 26.00% 20.00% 24.00% 31.00% 27.00% 27.00% 26.00% 25.00% 24.00% 27.00% 23.00% 19.00% 26.00%
Depreciation 7 6 6 6 6 6 5 5 5 5 4 4 5 4 4
Interest 2 2 2 2 2 4 1 2 1 2 2 2 2 2 2

Profit and Earnings

Profit Before Tax 15 18 11 5 5 6 6 5 5 5 3 4 4 4 5
Tax 4 7 1 1 1 1 1 0 2 2 1 1 1 0 1
Net Profit 10 11 10 5 5 6 5 5 2 3 2 4 3 4 4
EPS 4.62 4.96 4.59 2.03 2.11 2.66 2.08 2.17 1.10 1.46 0.98 1.68 1.46 2.04 2.16

Sakar Healthcare Cash Flow Screener - Liquidity Fundamentals

Screen SAKAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹49.

Over the same period, investing activities used ₹28 and financing activities used ₹21.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Cash from Operations and Investing

Operating Activities 49 34 25 33 36 15 19
Investing Activities -28 -31 -52 -74 -90 -47 -22

Financing and Net Cash

Financing Activities -21 -4 27 41 55 32 4
Net Cash Flow 0 0 0 0 0 0 0

Sakar Healthcare Shareholding Pattern Screener

See Sakar Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Sakar Healthcare promoter holding and ownership changes for SAKAR on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 52.52%, foreign institutions 12.14%, domestic institutions 11.37% and the public 19.96%, spread across 14,734 shareholders.

The shareholder count was 14,734 in 2026-Jun, compared with 9,580 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept

Promoter Holding

Promoter Holding 52.52% 52.86% 52.86% 52.86% 52.86% 53.58% 53.58% 53.15%

Institutional Investors

FII Holding 12.14% 12.94% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 11.37% 11.32% 11.36% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 19.96% 18.11% 16.59% 16.01% 15.86% 15.93% 15.75% 16.88%
Other Holding 4.02% 4.76% 19.20% 31.13% 31.28% 30.48% 30.67% 29.97%
Shareholder Count 14,734 9,580 7,069 7,565 8,115 8,608 8,598 7,867

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sakar Healthcare. Sakar Healthcare dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Sakar Healthcare.

Sakar Healthcare Stock Index Membership - Nifty & Sensex

See which indices include Sakar Healthcare stock. Check SAKAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Sakar Healthcare is not part of any tracked indices.
Only major market indices are tracked in our system.

Sakar Healthcare Market Events Screener - Corporate Actions

Get Sakar Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sakar Healthcare stock events that may affect SAKAR share price, along with derivatives, futures and options activity and sector gainers.

9 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated July 24, 2026, with a record date of July 24, 2026.

It is followed by Quarterly Result Announcement dated May 12, 2026 and Quarterly Result Announcement dated February 5, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-07-24 2026-07-24 Quarterly Result Announcement NA -5.71%
2026-05-12 2026-05-12 Quarterly Result Announcement NA -15.89%
2026-02-05 2026-02-05 Quarterly Result Announcement NA 5.67%
2025-11-07 2025-11-07 Quarterly Result Announcement NA 8.00%
2025-05-15 2025-05-15 Quarterly Result Announcement NA 15.50%
2025-02-08 2025-02-08 Quarterly Result Announcement NA 0.83%
2024-10-22 2024-10-22 Quarterly Result Announcement NA -0.03%
2024-09-21 2024-09-21 Annual General Meeting NA -2.20%
2023-12-20 2023-12-20 Extraordinary General Meeting NA -5.45%

Sakar Healthcare Competitors Screener - Peer Stocks Comparison

Screen SAKAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 435,863 36.83 61,674 12.69% 11,565 38.95
Divis Laboratories 246,660 86.00 11,067 13.95% 2,568 53.27
Torrent Pharmaceuticals 182,577 86.72 13,886 20.34% 2,138 42.82
Zydus Life Science 115,910 25.96 27,658 17.64% 5,026 51.33
Cipla 108,738 33.29 29,045 2.24% 3,870 35.23
Laurus Labs 106,982 98.39 6,868 22.01% 890 58.13
Mankind Pharma 103,418 50.84 14,636 14.85% 1,938 59.40
Dr Reddys Laboratories 102,916 32.77 35,059 3.90% 4,158 62.37
Aurobindo Pharma 96,203 26.41 34,145 5.56% 3,503 49.32
Lupin 92,839 16.97 29,039 26.75% 5,356 31.32

Sakar Healthcare Company Announcements - News & Reports Screener

Screen SAKAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 4, 2026.

The next most recent announcements are dated September 28, 2026 and September 28, 2026.

Date Update Actions
2026-10-04 Trading Window -
2026-09-28 Shareholders meeting -
2026-09-28 Shareholders meeting -
2026-09-28 Appointment -
2026-09-14 Analysts/Institutional Investor Meet/Con. Call Updates -
2026-09-14 Analysts/Institutional Investor Meet/Con. Call Updates -
2026-09-01 General Updates -
2026-08-29 Copy of Newspaper Publication -
2026-08-27 Shareholders meeting -
2026-08-03 Analysts/Institutional Investor Meet/Con. Call Updates -
2026-08-01 Copy of Newspaper Publication -
2026-07-29 Analysts/Institutional Investor Meet/Con. Call Updates -
2026-07-28 Investor Presentation -
2026-07-24 Outcome of Board Meeting -
2026-07-24 Press Release -
2026-07-24 Analysts/Institutional Investor Meet/Con. Call Updates -
2026-07-20 General Updates -
2026-07-09 Disclosure under SEBI Takeover Regulations -
2026-07-08 General Updates -
2026-06-26 Trading Window -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹1,006.80, within a 52-week range of ₹353.00 to ₹1,188.40. The P/E ratio is 69.16 and the P/B ratio is 7.69, with earnings per unit of ₹13.70. Market capitalisation stands at ₹2,432.03 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE. Key statistics were last updated on October 6, 2026. This page covers 7 balance sheet periods, 15 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.